Trial Profile
Serum biomarkers in predicting prognosis and liver function deterioration in sorafenib treated patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Jul 2017 New trial record